Filing Flows › Marimed (MRMD) › Q2 2025
Marimed (MRMD) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 7, 2025
Marimed (MRMD) reported revenue of $39.5M for the second quarter 2025 (Q2 2025), -2% from a year earlier and +4% from the quarter before. Operating margin was 2.9%, net loss $1.3M (3.2% of revenue).
Marimed, Q2 2025: revenue $39.5M (-2% year over year), operating margin 2.9%, net loss $1.3M, operating cash flow $297K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $39.5M | +4% | -2% |
| Operating profit | $1.1M | — | — |
| Net earnings | −$1.3M | — | — |
| Operating cash flow | $297K | -77% | -91% |
What changed
Revenue was $39.5M in Q2 2025, down 2% year over year and up 4% from the previous quarter. Product sales - retail was the largest line at 57% of revenue. Product sales - retail lost $1.2M year over year (down 5%), 127% of the total change.
Gross margin was 40.3%, down 1.5 points from a year earlier. Operating profit was $1.1M, a 2.9% margin (up 0.5 points year over year). Operating expenses fell 7% while revenue fell 2%. The quarter ended with a net loss of $1.3M, narrower than the previous quarter's $5.5M loss. Net interest and other expense of $1.7M was the main reason.
Operating cash flow was $297K (down 91% year over year). Non-cash charges added back $2.1M of depreciation and amortization and $549K of share-based compensation. Working capital and other items used $1.1M. Capital expenditures of $309K exceeded it, leaving free cash flow of −$12K.
Questions
What was Marimed's revenue in the second quarter 2025?
Marimed (MRMD) reported revenue of $39.5M for the second quarter 2025 (Q2 2025), -2% from a year earlier and +4% from the quarter before.
Was Marimed profitable in the second quarter 2025?
Operating profit was $1.1M (2.9% of revenue) and net loss $1.3M.
Source: Marimed 10-Q on SEC EDGAR.